| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4012d77767997bc3ef3ab23cb1c4e2d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76145c9dea1c05bfaf4a7bf15cb9fcaf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa0ea4c0daae6ab4f7f115ced29e2753 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16151
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16121
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16021 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 |
| filingDate |
2020-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fcbe2b27a87e227404f45440a8dddab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cef13babb661c2f28ceef815dbadae66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_208ae8c1c0f4a829a0bd3c06e9e5223d |
| publicationDate |
2021-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021041624-A2 |
| titleOfInvention |
Recombinant influenza viruses with stabilized ha for replication in eggs |
| abstract |
Modified influenza virus neuraminidases are described herein that improve viral replication, thus improving the yield of vaccine viruses. Expression of such modified neuraminidases by influenza virus may also stabilize co-expressed hemagglutinins so that the hemagglutinins do not undergo mutation or decrease the need for HA binding to cells. |
| priorityDate |
2019-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |